About us

Contact: Mark Tyrrell, CEO, mark@vitae-evidence.com

Write to us


Vitae Evidence AS is an innovative, cutting edge startup established in April 2022 as a spin-off of the PubGene company. Its focus is the development and commercialization of a cloud-based Medical Device software solution specialising in personalised medicine and powered by AI-Human collaboration.

Intended Use To aid the shared clinical decision and facilitate the patient-clinician-researcher collaboration.
Indications Patients diagnosed with cancer, auto-immune or neurodegenerative diseases
Contraindication None

Read the Instruction For Use

“Our raison d'être is to improve shared decision making, improve patient outcomes and assist clinicians in staying abreast of the latest treatment options.”

Dr Mark Tyrrell, CEO and Medical Director

Located in Oslo, Norway.

We picked our office location to maximize our team's potential! Oslo's best meeting place for innovators paving the way for Norway’s future is the Science Park, within walking distance of our office, as well as Athletica Domus, the city's largest training center. Come visit us and you'll agree.

Contact us

Would you like to partner with us?

Hit us up and we'll get in touch with you.